2.21
In 8 Bio Inc Azioni (INAB) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
2.73%
0.107
|
0.11 | 0.064 | 0.023 | 0.06 |
|
8.11%
5.201
|
5.66 | 6.224 | 7.109 | 8.689 |
Benefits Costs and Expenses |
8.11%
5.201
|
5.66 | 11.78 | 7.109 | 8.689 |
Costs And Expenses |
8.11%
5.201
|
5.66 | 6.224 | 7.109 | 8.689 |
Operating Income/Loss |
8.22%
-5.094
|
-5.55 | -6.16 | -7.086 | -8.629 |
Income/Loss From Continuing Operations Before Tax |
8.22%
-5.094
|
-5.55 | -11.71 | -7.086 | -8.629 |
Income/Loss From Continuing Operations After Tax |
8.22%
-5.094
|
-5.55 | -6.16 | -7.086 | -8.629 |
|
8.22%
-5.094
|
-5.55 | -6.16 | -7.086 | -8.629 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
95.07%
4.1192
|
83.48 | 7.8564 | 47.32 | 45.13 |
Diluted Average Shares |
95.07%
4.1192
|
83.48 | 7.8564 | 47.32 | 45.13 |
Basic Earnings Per Share |
1,671%
-1.24
|
-0.07 | -0.04 | -0.15 | -0.19 |
Diluted Earnings Per Share |
1,671%
-1.24
|
-0.07 | -0.04 | -0.15 | -0.19 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):